ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 2 filers reported holding ENDOCYTE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,373,000 | +28.7% | 77,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,067,000 | -41.3% | 77,300 | -61.4% | 0.00% | 0.0% |
| Q1 2018 | $1,818,000 | +3536.0% | 200,000 | +925.6% | 0.00% | – |
| Q1 2017 | $50,000 | 0.0% | 19,500 | 0.0% | 0.00% | – |
| Q4 2016 | $50,000 | -16.7% | 19,500 | 0.0% | 0.00% | – |
| Q3 2016 | $60,000 | -10.4% | 19,500 | -7.1% | 0.00% | – |
| Q2 2016 | $67,000 | +19.6% | 21,000 | +15.4% | 0.00% | – |
| Q1 2016 | $56,000 | -42.3% | 18,200 | -24.5% | 0.00% | – |
| Q4 2015 | $97,000 | -11.8% | 24,100 | 0.0% | 0.00% | – |
| Q3 2015 | $110,000 | -12.0% | 24,100 | 0.0% | 0.00% | – |
| Q2 2015 | $125,000 | -3.1% | 24,100 | +17.0% | 0.00% | – |
| Q1 2015 | $129,000 | -22.3% | 20,600 | -22.0% | 0.00% | – |
| Q4 2014 | $166,000 | -21.0% | 26,400 | -23.5% | 0.00% | – |
| Q3 2014 | $210,000 | -7.5% | 34,500 | 0.0% | 0.00% | – |
| Q2 2014 | $227,000 | -83.2% | 34,500 | -39.3% | 0.00% | -100.0% |
| Q1 2014 | $1,353,000 | +106.2% | 56,827 | -7.3% | 0.00% | 0.0% |
| Q4 2013 | $656,000 | -28.7% | 61,321 | -11.2% | 0.00% | 0.0% |
| Q3 2013 | $920,000 | +1.5% | 69,021 | +0.0% | 0.00% | 0.0% |
| Q2 2013 | $906,000 | – | 69,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |